Company Filing History:
Years Active: 2017-2022
Title: Fredrick E Hargreave: Innovator in Medical Treatments
Introduction
Fredrick E Hargreave is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of medical treatments, particularly in the area of eosinophilic bronchitis. With a total of two patents to his name, Hargreave's work focuses on innovative methods that address critical health conditions.
Latest Patents
Hargreave's latest patents include methods for the treatment of eosinophilic bronchitis using an anti-IL-5 antibody. The present invention relates to the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production. More specifically, it involves monoclonal antibodies (mAbs), Fabs, chimeric, and humanized antibodies. This innovative approach aims to provide effective treatment options for patients suffering from eosinophilic bronchitis.
Career Highlights
Fredrick E Hargreave is associated with GlaxoSmithKline LLC, where he continues to contribute to advancements in medical research and treatment methodologies. His work has garnered attention for its potential impact on patient care and treatment efficacy.
Collaborations
Hargreave collaborates with Giampietro Ventresca, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Fredrick E Hargreave's contributions to medical treatments, particularly through his patents on eosinophilic bronchitis, highlight his role as an influential inventor. His work continues to pave the way for advancements in healthcare solutions.